Tuesday, August 08, 2023 11:02:53 AM
............ why are they having such a hard time getting someone to partner with?
The same reason no one would partner with them or buy them out when they were touting tolloVIR as a potential cure for covid.
Because their products are garbage.
Merck was getting its ass handed to them when Pfizer had Paxlovid being given out to the masses. Merck and others would have gladly partnered with Todos if they felt Tollovir had any chance.
AMAZINGLY NOT ONE BIG PHARMA WENT AFTER TODOS.
Now the goalposts have been moved yet again.
This time tolloVID will be the answer to long covid.
Guess what. NO One will partner with them again because if Tollovid was any good it would have already happened.
GC will be moving the goalpost soon enough.
Probably gonna push his famed Alzheimer or breast cancer tests.
And this sad saga continues on and on.
Meanwhile all shareholders have been royally screwed.
This is all in my opinion of course but I seem to be correct more than wrong.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM